Azithromycin reduces the viability of human bronchial smooth muscle cells

Rodopi Stamatiou, Konstantinos Boukas, Efrosyni Paraskeva, Paschalis Adam Molyvdas, Apostolia Hatziefthimiou

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

The macrolide antibiotic azithromycin has an antiproliferative and autophagic effect on rabbit tracheal smooth muscle cells (SMCs). The purpose of this study is to investigate the effect of azithromycin on human bronchial SMCs. Human bronchial SMCs were treated with azithromycin (10 5 M) in the presence or absence of 10% fetal bovine serum (FBS). Cell number was estimated using the Cell Titer 96 AQ ueous One Solution Assay. Induction of autophagy was studied by observation of cell morphology in cells treated or not with the autophagy inhibitor, 3-methyladenine (3-MA), as well as by Lysotracker Red staining of lysosomes. Activation of apoptosis was assessed with flow cytometry after annexin staining. Incubation with azithromycin for 24, 48 or 72 h reduced viability in FBS-deprived cells, as well as cells cultured in FBS-containing medium. Azithromycin treatment resulted in the formation of cytoplasmic vacuoles that could not be prevented by 3-MA. Furthermore, 3-MA did not reverse the effect of azithromycin on the viability of SMCs. There was an increase in the number of lysosomes in cells treated with azithromycin. Finally, azithromycin increased the percentage of early apoptotic cells. In conclusion, azithromycin reduces the viability of human bronchial SMCs possibly by leading to apoptotic cell death.

Original languageEnglish
Pages (from-to)71-75
Number of pages5
JournalJournal of Antibiotics
Volume63
Issue number2
DOIs
StatePublished - Feb 1 2010
Externally publishedYes

Fingerprint

Azithromycin
Smooth Muscle Myocytes
Autophagy
Lysosomes
Fetal Viability
Serum
Staining and Labeling
Annexins
Macrolides
Vacuoles
Cultured Cells
Flow Cytometry
Cell Death
Cell Count
Observation
Apoptosis
Anti-Bacterial Agents
Rabbits

Keywords

  • Apoptosis
  • Autophagy
  • Azithromycin
  • Human bronchial SMCs
  • Viability

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Stamatiou, R., Boukas, K., Paraskeva, E., Molyvdas, P. A., & Hatziefthimiou, A. (2010). Azithromycin reduces the viability of human bronchial smooth muscle cells. Journal of Antibiotics, 63(2), 71-75. https://doi.org/10.1038/ja.2009.125

Azithromycin reduces the viability of human bronchial smooth muscle cells. / Stamatiou, Rodopi; Boukas, Konstantinos; Paraskeva, Efrosyni; Molyvdas, Paschalis Adam; Hatziefthimiou, Apostolia.

In: Journal of Antibiotics, Vol. 63, No. 2, 01.02.2010, p. 71-75.

Research output: Contribution to journalArticle

Stamatiou, R, Boukas, K, Paraskeva, E, Molyvdas, PA & Hatziefthimiou, A 2010, 'Azithromycin reduces the viability of human bronchial smooth muscle cells', Journal of Antibiotics, vol. 63, no. 2, pp. 71-75. https://doi.org/10.1038/ja.2009.125
Stamatiou R, Boukas K, Paraskeva E, Molyvdas PA, Hatziefthimiou A. Azithromycin reduces the viability of human bronchial smooth muscle cells. Journal of Antibiotics. 2010 Feb 1;63(2):71-75. https://doi.org/10.1038/ja.2009.125
Stamatiou, Rodopi ; Boukas, Konstantinos ; Paraskeva, Efrosyni ; Molyvdas, Paschalis Adam ; Hatziefthimiou, Apostolia. / Azithromycin reduces the viability of human bronchial smooth muscle cells. In: Journal of Antibiotics. 2010 ; Vol. 63, No. 2. pp. 71-75.
@article{80318abcfa524996b3818f4fa9411b94,
title = "Azithromycin reduces the viability of human bronchial smooth muscle cells",
abstract = "The macrolide antibiotic azithromycin has an antiproliferative and autophagic effect on rabbit tracheal smooth muscle cells (SMCs). The purpose of this study is to investigate the effect of azithromycin on human bronchial SMCs. Human bronchial SMCs were treated with azithromycin (10 5 M) in the presence or absence of 10{\%} fetal bovine serum (FBS). Cell number was estimated using the Cell Titer 96 AQ ueous One Solution Assay. Induction of autophagy was studied by observation of cell morphology in cells treated or not with the autophagy inhibitor, 3-methyladenine (3-MA), as well as by Lysotracker Red staining of lysosomes. Activation of apoptosis was assessed with flow cytometry after annexin staining. Incubation with azithromycin for 24, 48 or 72 h reduced viability in FBS-deprived cells, as well as cells cultured in FBS-containing medium. Azithromycin treatment resulted in the formation of cytoplasmic vacuoles that could not be prevented by 3-MA. Furthermore, 3-MA did not reverse the effect of azithromycin on the viability of SMCs. There was an increase in the number of lysosomes in cells treated with azithromycin. Finally, azithromycin increased the percentage of early apoptotic cells. In conclusion, azithromycin reduces the viability of human bronchial SMCs possibly by leading to apoptotic cell death.",
keywords = "Apoptosis, Autophagy, Azithromycin, Human bronchial SMCs, Viability",
author = "Rodopi Stamatiou and Konstantinos Boukas and Efrosyni Paraskeva and Molyvdas, {Paschalis Adam} and Apostolia Hatziefthimiou",
year = "2010",
month = "2",
day = "1",
doi = "10.1038/ja.2009.125",
language = "English",
volume = "63",
pages = "71--75",
journal = "Journal of Antibiotics",
issn = "0021-8820",
publisher = "Japan Antibiotics Research Association",
number = "2",

}

TY - JOUR

T1 - Azithromycin reduces the viability of human bronchial smooth muscle cells

AU - Stamatiou, Rodopi

AU - Boukas, Konstantinos

AU - Paraskeva, Efrosyni

AU - Molyvdas, Paschalis Adam

AU - Hatziefthimiou, Apostolia

PY - 2010/2/1

Y1 - 2010/2/1

N2 - The macrolide antibiotic azithromycin has an antiproliferative and autophagic effect on rabbit tracheal smooth muscle cells (SMCs). The purpose of this study is to investigate the effect of azithromycin on human bronchial SMCs. Human bronchial SMCs were treated with azithromycin (10 5 M) in the presence or absence of 10% fetal bovine serum (FBS). Cell number was estimated using the Cell Titer 96 AQ ueous One Solution Assay. Induction of autophagy was studied by observation of cell morphology in cells treated or not with the autophagy inhibitor, 3-methyladenine (3-MA), as well as by Lysotracker Red staining of lysosomes. Activation of apoptosis was assessed with flow cytometry after annexin staining. Incubation with azithromycin for 24, 48 or 72 h reduced viability in FBS-deprived cells, as well as cells cultured in FBS-containing medium. Azithromycin treatment resulted in the formation of cytoplasmic vacuoles that could not be prevented by 3-MA. Furthermore, 3-MA did not reverse the effect of azithromycin on the viability of SMCs. There was an increase in the number of lysosomes in cells treated with azithromycin. Finally, azithromycin increased the percentage of early apoptotic cells. In conclusion, azithromycin reduces the viability of human bronchial SMCs possibly by leading to apoptotic cell death.

AB - The macrolide antibiotic azithromycin has an antiproliferative and autophagic effect on rabbit tracheal smooth muscle cells (SMCs). The purpose of this study is to investigate the effect of azithromycin on human bronchial SMCs. Human bronchial SMCs were treated with azithromycin (10 5 M) in the presence or absence of 10% fetal bovine serum (FBS). Cell number was estimated using the Cell Titer 96 AQ ueous One Solution Assay. Induction of autophagy was studied by observation of cell morphology in cells treated or not with the autophagy inhibitor, 3-methyladenine (3-MA), as well as by Lysotracker Red staining of lysosomes. Activation of apoptosis was assessed with flow cytometry after annexin staining. Incubation with azithromycin for 24, 48 or 72 h reduced viability in FBS-deprived cells, as well as cells cultured in FBS-containing medium. Azithromycin treatment resulted in the formation of cytoplasmic vacuoles that could not be prevented by 3-MA. Furthermore, 3-MA did not reverse the effect of azithromycin on the viability of SMCs. There was an increase in the number of lysosomes in cells treated with azithromycin. Finally, azithromycin increased the percentage of early apoptotic cells. In conclusion, azithromycin reduces the viability of human bronchial SMCs possibly by leading to apoptotic cell death.

KW - Apoptosis

KW - Autophagy

KW - Azithromycin

KW - Human bronchial SMCs

KW - Viability

UR - http://www.scopus.com/inward/record.url?scp=77950233254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77950233254&partnerID=8YFLogxK

U2 - 10.1038/ja.2009.125

DO - 10.1038/ja.2009.125

M3 - Article

C2 - 20075980

AN - SCOPUS:77950233254

VL - 63

SP - 71

EP - 75

JO - Journal of Antibiotics

JF - Journal of Antibiotics

SN - 0021-8820

IS - 2

ER -